Technical Analysis for VRNA - Verona Pharma plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 15.58 | 1.76% | 0.27 |
VRNA closed up 0.46 percent on Thursday, April 25, 2024, on 1.17 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 1.76% | |
| BB Squeeze Ended | Range Expansion | 1.76% | |
| Lower Bollinger Band Touch | Weakness | 1.76% | |
| Oversold Stochastic | Weakness | 1.76% | |
| Bollinger Band Squeeze | Range Contraction | 2.23% | |
| Lower Bollinger Band Walk | Weakness | 2.23% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 2.23% | |
| Gapped Up | Strength | 2.23% | |
| Below Lower BB | Weakness | 2.23% | |
| Lower Bollinger Band Touch | Weakness | 2.23% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 3 hours ago |
| Rose Above Previous Day's High | about 4 hours ago |
| Up 1% | about 4 hours ago |
| Up 1% | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company's lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Asthma Respiratory Therapy Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Asthma Respiratory Therapy Chronic Obstructive Pulmonary Disease Respiratory Diseases Cystic Fibrosis Phosphodiesterase Lung Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 23.81 |
| 52 Week Low | 11.83 |
| Average Volume | 428,561 |
| 200-Day Moving Average | 16.91 |
| 50-Day Moving Average | 16.39 |
| 20-Day Moving Average | 16.08 |
| 10-Day Moving Average | 15.80 |
| Average True Range | 0.65 |
| RSI (14) | 39.02 |
| ADX | 11.72 |
| +DI | 12.84 |
| -DI | 22.95 |
| Chandelier Exit (Long, 3 ATRs) | 15.30 |
| Chandelier Exit (Short, 3 ATRs) | 16.85 |
| Upper Bollinger Bands | 16.98 |
| Lower Bollinger Band | 15.19 |
| Percent B (%b) | 0.07 |
| BandWidth | 11.12 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.17 |
| MACD Histogram | -0.0843 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.14 | ||||
| Resistance 3 (R3) | 16.09 | 15.77 | 16.00 | ||
| Resistance 2 (R2) | 15.77 | 15.56 | 15.79 | 15.95 | |
| Resistance 1 (R1) | 15.54 | 15.43 | 15.66 | 15.59 | 15.91 |
| Pivot Point | 15.22 | 15.22 | 15.28 | 15.24 | 15.22 |
| Support 1 (S1) | 14.99 | 15.01 | 15.11 | 15.04 | 14.71 |
| Support 2 (S2) | 14.67 | 14.88 | 14.69 | 14.67 | |
| Support 3 (S3) | 14.44 | 14.67 | 14.62 | ||
| Support 4 (S4) | 14.49 |
